Articles by John A. Merenich, MD
Positive Predictive Values of ICD-9 Codes to Identify Patients With Stroke or TIA
ByKari L. Olson, BSc(Pharm), PharmD,Michele D. Wood, PharmD,Thomas Delate, PhD,Lisa J. Lash, PharmD,Jon Rasmussen, PharmD,Anne M. Denham, PharmD,John A. Merenich, MD This study determined that ICD-9 codes 433.X1, 434.XX, and V12.54 had positive predictive values >90%, and may be used to focus care on stroke patients.
Outcomes of Patients Discharged From Pharmacy-Managed Cardiovascular Disease Management
ByKari L. Olson, PharmD,Thomas Delate, PhD,Jon Rasmussen, PharmD,Tammy L. Humphries, PharmD,John A. Merenich, MD,for the Clinical Pharmacy Cardiac Risk Service Study Group Lipid levels can remain controlled with electronic laboratory reminder letters for most patients with coronary artery disease discharged from a cardiovascular disease management program.
Angiotensin-converting Enzyme Inhibitor Therapy for Coronary Artery Disease and Diabetes Mellitus
ByKaren J. McConnell, PharmD,Emily B. Zadvorny, PharmD,Anne M. Denham, PharmD,Sheila L. Kasten, PharmD,Kara A. Hutka, PharmD,Cedar R. Koetting, PharmD,John A. Merenich, MD,for the Clinical Pharmacy Cardiac Risk Service Study Group The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) Study: Evaluating the Role of Drug Therapy Within a Weight Management Program in a Group-Model Health Maintenance Organizati
ByJulie A. Porter, PharmD,Marsha A. Raebel, PharmD,Douglas A. Conner, PhD,Frances A. Lanty, PharmD,Erin A. Vogel, PharmD,Elizabeth C. Gay, MA,John A. Merenich, MD